Related Experiment Video
Updated: Jul 19, 2025

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
Integrating Concentration-Dependent Toxicity Data and Toxicokinetics To Inform Hepatotoxicity Response Pathways
Daniel P Russo1, Lauren M Aleksunes2, Katy Goyak3
1Department of Chemistry and Biochemistry, Rowan University, Glassboro, New Jersey 08028, United States.
Developing new computational models for predicting liver toxicity (hepatotoxicity) is crucial. This study presents a novel strategy using high-throughput screening assays to build pathway-based models for improved chemical safety assessments.
Area of Science:
- Computational toxicology
- Chemical safety assessment
- In vitro toxicology
Background:
- Animal models often fail to predict human liver toxicity.
- In vitro high-throughput screening (HTS) assays offer an alternative but require pathway-based models for complex toxicities.
- Existing models for simple pathways are successful, but complex toxicities like hepatotoxicity remain challenging.
Purpose of the Study:
- To develop a computational strategy for creating pathway-based models for complex toxicities, specifically human hepatotoxicity.
- To identify and group in vitro assays relevant to hepatotoxicity mechanisms.
- To improve the prediction of in vivo hepatotoxicity using these models.
Main Methods:
- Utilized a database of 2171 chemicals with human hepatotoxicity classifications.
- Screened 1600+ ToxCast/Tox21 HTS assays to identify those associated with hepatotoxicity.
- Developed a computational framework to group assays into 52 key event (KE) models based on biological targets/mechanisms.
- Employed supervised learning with KE scores and toxicokinetic information for prediction.
Main Results:
- Identified 157 HTS assays linked to human hepatotoxicity.
- Grouped assays into 52 KE models, generating KE scores for chemical potency.
- Observed that chemical structure groupings with high KE scores plausibly indicated hepatotoxicity mechanisms.
- Achieved improved prediction of in vivo hepatotoxicity by integrating KE scores and toxicokinetic data.
Conclusions:
- The developed computational strategy provides a universal approach for pathway-based modeling of complex toxicities.
- This method enhances the prediction of chemical-induced liver injury.
- The strategy holds potential for broader applications in chemical toxicity evaluations.
Related Concept Videos
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

